Global Clinical Nutrition Products Market to Reach $58.7 Billion by 2027
Amid the COVID-19 crisis, the global market for Clinical Nutrition Products estimated at US$40.8 Billion in the year 2020, is projected to reach a revised size of US$58.7 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Infant Nutrition, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$35.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enteral Nutrition segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $11 Billion, While China is Forecast to Grow at 8.3% CAGR
The Clinical Nutrition Products market in the U.S. is estimated at US$11 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.3 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.
Parenteral Nutrition Segment to Record 4% CAGR
In the global Parenteral Nutrition segment, USA, Canada, Japan, China and Europe will drive the 3.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.3 Billion in the year 2020 will reach a projected size of US$4.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.9 Billion by the year 2027, while Latin America will expand at a 5% CAGR through the analysis period.
Select Competitors (Total 67 Featured):
Amid the COVID-19 crisis, the global market for Clinical Nutrition Products estimated at US$40.8 Billion in the year 2020, is projected to reach a revised size of US$58.7 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Infant Nutrition, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$35.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enteral Nutrition segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $11 Billion, While China is Forecast to Grow at 8.3% CAGR
The Clinical Nutrition Products market in the U.S. is estimated at US$11 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.3 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.
Parenteral Nutrition Segment to Record 4% CAGR
In the global Parenteral Nutrition segment, USA, Canada, Japan, China and Europe will drive the 3.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.3 Billion in the year 2020 will reach a projected size of US$4.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.9 Billion by the year 2027, while Latin America will expand at a 5% CAGR through the analysis period.
Select Competitors (Total 67 Featured):
- Abbott Nutrition
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Kabi AG
- Groupe Danone
- ICU Medical Inc.
- Mead Johnson & Company LLC
- Meiji Co. Ltd.
- Nestlé Health Science S.A
- Nutricia North America
- Otsuka Pharmaceutical Factory Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
III. MARKET ANALYSIS
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Clinical Nutrition Products: Essential for Addressing Disease-Related Malnutrition
- Recent Market Activity
- Clinical Nutrition Market Poised for Healthy Growth
- Segment Analysis
- Developed Regions Lead, Asia-Pacific to Command Higher Market Share
- Infant Nutrition Market: The Leading Segment with High Growth Potential
- Need for Nutritional Support - Essential for Preterm Infants
- Inadequate Physiological Development Raises Need for Tube Feeding in Infants
- Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
- Developing Economies Promise New Opportunities for Infant Nutrition
- Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
- Parenteral Nutrition Market to Maintain Upward Trajectory
- US Rules the Global Parenteral Nutrition Market
- Key Issues Governing the Parenteral Nutrition Market
- Enteral Nutrition Market to Remain Buoyant and Strong
- Standard Enteral Nutrition Formulations Lead EN Products Market
- Oncology Applications Leads EN Market
- Hospitals & Long-term Care Facilities: The Major Users of EN Products
- New Launches Bolster Market Growth
- Rising Incidence of Chronic Diseases: An Opportunity Indicator for Enteral Nutrition
- Launch of Enhanced Formulas Enables to Tap the Unmet Need
- The US Dominates Enteral Nutrition Market
- Market Restrains
- Impact of Covid-19 and a Looming Global Recession
- Abbott Nutrition (USA)
- Baxter International, Inc. (USA)
- B. Braun Melsungen AG (Germany)
- Fresenius Kabi AG (Germany)
- Groupe Danone (France)
- Nutricia North America (USA)
- ICU Medical, Inc. (USA)
- Mead Johnson & Company, LLC. (USA)
- Meiji Co., Ltd. (Japan)
- Nestlé Health Science S.A (Switzerland)
- Otsuka Pharmaceutical Factory, Inc. (Japan)
- Otsuka Pharmaceutical India Pvt. Ltd. (India)
- Research Efforts and Advanced Formulations to Fuel Clinical Nutrition Market
- Sustained Increase in Healthcare Spending Bodes Well for Clinical Nutrition Market
- Aging Population Worldwide: Rising Need for Added Nutritional Support to Propel Market Growth
- Rising Incidence of Chronic Diseases to Kindle Market Growth
- Cancer - The Major Chronic Illness Requiring Clinical Nutrition Support
- Critical Nutrition Products Vital for Preventing Malnutrition in Diabetics
- Persistent Threat of HIV/AIDS Infection: An Opportunity for Medical Nutrition Market
- Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
- Non-volitional Nutritional Support Therapy: Vital for Combating Malnutrition during Hospitalization
- Shift towards Home Care Boosts Demand for Clinical Nutrition Products
- Changing Health and Social Care Factors Favor Home Enteral Feeding
- Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
- Preterm Birth Statistics from WHO
- Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
- Product Innovations Blur the Lines between Medicine and Foods
- Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
- Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
- Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market
- Specialized Formula Products Inundate the Market
- Soy-based Infant Formula Gains Popularity
- Pre-mixed IV Solutions: A Step towards Safer Medication Practices
- Growing Demand for Low-Cost Parenteral Nutrition Solutions
- Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
- Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
- Infection Control: A Prime Concern in Parenteral Nutrition
- Complacency of Hospitals & Worker/Patient Safety: A Key Issue
- Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
- Rising Preference for Enteral Nutrition - A Threat to Parenteral Nutrition Market
- Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
- Major Challenges Confronting Medical Nutrition Products’ Marketers
- Barriers to Widespread Adoption of Clinical Nutrition Products
- Reasons for Not Prescribing Clinical Nutrition Products
III. MARKET ANALYSIS
- UNITED STATES
- CANADA
- JAPAN
- CHINA
- EUROPE
- FRANCE
- GERMANY
- ITALY
- UNITED KINGDOM
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA-PACIFIC
- AUSTRALIA
- INDIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- LATIN AMERICA
- ARGENTINA
- BRAZIL
- MEXICO
- REST OF LATIN AMERICA
- MIDDLE EAST
- IRAN
- ISRAEL
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- REST OF MIDDLE EAST
- AFRICA
- Total Companies Profiled: 67
Note: Product cover images may vary from those shown
